Literature DB >> 19452348

Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis.

Debra D Poutsiaka1, Lisa E Davidson, Katherine L Kahn, David W Bates, David R Snydman, Patricia L Hibberd.   

Abstract

Few studies have focused on sepsis in patients with pre-existing immunosuppression. Since the numbers and the incidence of sepsis are increasing, sepsis in immunosuppressed patients will increase in importance. We studied the epidemiology of sepsis and risk factors for 28-d mortality in patients immunosuppressed prior to the onset of sepsis using data from the Academic Medical Center Consortium's (AMCC) prospective observational cohort study of sepsis. We compared characteristics of immunosuppressed (n =412) and immunocompetent (n =754) patients. Immunosuppressed patients were younger and more likely to have underlying liver or lung disease, and nosocomial infection or bloodstream infection of unknown source when presenting with sepsis. They were also more likely to die within 28 d compared to immunocompetent patients (adjusted relative risk 1.62, 95% CI 1.38 - 1.91). Septic shock, hypothermia, cancer and invasive fungal infections were associated with increased mortality in immunosuppressed patients. Black race and the presence of rigors were independent predictors of survival in immunosuppressed patients. We conclude that sepsis among patients immunosuppressed prior to the onset of sepsis was associated with higher mortality than in immunocompetent patients. As the numbers of immunosuppressed patients continue to grow, more studies on the epidemiology of sepsis in this group will become increasingly important.

Entities:  

Mesh:

Year:  2009        PMID: 19452348      PMCID: PMC4129637          DOI: 10.1080/00365540902962756

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  37 in total

Review 1.  Predicting outcome in critical care: the current status of the APACHE prognostic scoring system.

Authors:  D T Wong; W A Knaus
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 2.  Signal detectability: the use of ROC curves and their analyses.

Authors:  R M Centor
Journal:  Med Decis Making       Date:  1991 Apr-Jun       Impact factor: 2.583

3.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.

Authors:  J P Mira; A Cariou; F Grall; C Delclaux; M R Losser; F Heshmati; C Cheval; M Monchi; J L Teboul; F Riché; G Leleu; L Arbibe; A Mignon; M Delpech; J F Dhainaut
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

4.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.

Authors:  W D Döcke; F Randow; U Syrbe; D Krausch; K Asadullah; P Reinke; H D Volk; W Kox
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

5.  Epidemiology of sepsis syndrome in 8 academic medical centers.

Authors:  K E Sands; D W Bates; P N Lanken; P S Graman; P L Hibberd; K L Kahn; J Parsonnet; R Panzer; E J Orav; D R Snydman; E Black; J S Schwartz; R Moore; B L Johnson; R Platt
Journal:  JAMA       Date:  1997-07-16       Impact factor: 56.272

6.  Epidemiology of sepsis in patients with traumatic injury.

Authors:  Tiffany Medlin Osborn; J Kathleen Tracy; James R Dunne; Michael Pasquale; Lena M Napolitano
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

7.  African-American and white patients admitted to the intensive care unit: is there a difference in therapy and outcome?

Authors:  J F Williams; J E Zimmerman; D P Wagner; M Hawkins; W A Knaus
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

Review 8.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

9.  Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients.

Authors:  D Pittet; B Thiévent; R P Wenzel; N Li; R Auckenthaler; P M Suter
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

10.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Authors:  C Brun-Buisson; F Doyon; J Carlet; P Dellamonica; F Gouin; A Lepoutre; J C Mercier; G Offenstadt; B Régnier
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

View more
  14 in total

1.  Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases.

Authors:  Jared A Greenberg; Samuel F Hohmann; Jesse B Hall; John P Kress; Michael Z David
Journal:  Ann Am Thorac Soc       Date:  2016-02

2.  Pre-B-cell colony-enhancing factor and its clinical correlates with acute lung injury and sepsis.

Authors:  Kathleen A Lee; Michelle N Gong
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

3.  Evaluation of a novel 5-group classification system of sepsis by vasopressor use and initial serum lactate in the emergency department.

Authors:  Kai E Swenson; James D Dziura; Ani Aydin; Jesse Reynolds; Charles R Wira
Journal:  Intern Emerg Med       Date:  2017-01-28       Impact factor: 3.397

4.  Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study.

Authors:  Cheng-Wei Chang; Victor C Kok; Ta-Chien Tseng; Jorng-Tzong Horng; Chun-Eng Liu
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study.

Authors:  G Sasson; A D Bai; A Showler; L Burry; M Steinberg; D R Ricciuto; T Fernandes; A Chiu; S Raybardhan; M Science; E Fernando; A M Morris; C M Bell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-01       Impact factor: 3.267

6.  Body computed tomography in sepsis: predictors of CT findings and patient outcomes in a retrospective medical ICU cohort study.

Authors:  Julian Pohlan; Denis Witham; Lara Farkic; Melina Anhamm; Alexandra Schnorr; Gloria Muench; Karim Breiling; Robert Ahlborn; Enrico Herz; Kerstin Rubarth; Damaris Praeger; Marc Dewey
Journal:  Emerg Radiol       Date:  2022-08-04

7.  Hospital Volume of Immunosuppressed Patients with Sepsis and Sepsis Mortality.

Authors:  Jared A Greenberg; Samuel F Hohmann; Bryan D James; Raj C Shah; Jesse B Hall; John P Kress; Michael Z David
Journal:  Ann Am Thorac Soc       Date:  2018-08

8.  Risk factors for hospitalization due to community-acquired sepsis - a population-based case-control study.

Authors:  Daniel Pilsgaard Henriksen; Anton Pottegård; Christian B Laursen; Thøger Gorm Jensen; Jesper Hallas; Court Pedersen; Annmarie Touborg Lassen
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

9.  Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality.

Authors:  Jared A Greenberg; Michael Z David; Jesse B Hall; John P Kress
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

10.  Use of methylene blue for treatment of severe sepsis in an immunosuppressed patient after liver transplantation.

Authors:  Saravanan Ramamoorthy; Shachi Patel; Eric Bradburn; Zakiyah Kadry; Tadahiro Uemura; Piotr K Janicki; Riaz Ali Shah; Dmitri Bezinover
Journal:  Case Rep Transplant       Date:  2013-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.